L87.1 Reactive perforating collagenosis

Name of the Condition

• Reactive perforating collagenosis

Summary

Reactive perforating collagenosis is a rare skin condition characterized by the abnormal elimination of collagen through the epidermis, resulting in papules, nodules, or plaques. The condition involves the extrusion of dermal collagen through the skin surface, often leading to pruritic or tender lesions. It is considered a transepidermal elimination disorder, with mechanisms linked to impaired skin barrier function or abnormal tissue processing.

Causes

The exact causes of reactive perforating collagenosis are not fully understood but are thought to involve dysregulation of skin cell turnover or extracellular matrix components. Some cases may be associated with genetic factors, autoimmune processes, or underlying systemic conditions that affect skin integrity. The elimination of collagen through the epidermis is believed to be a reactive process to abnormal material accumulation in the skin.

Risk Factors

• Genetic predisposition: Some forms may have familial patterns.
• Underlying systemic diseases: Conditions affecting skin or connective tissue may increase risk.
• Age: Certain subtypes may be more common in specific age groups.
• Skin trauma or irritation: May trigger or exacerbate lesions in susceptible individuals.

Symptoms

• Persistent papules, nodules, or plaques, often with a central keratotic plug.
• Pruritus or tenderness at lesion sites.
• Lesions typically appear on the trunk, extremities, or face.
• Lesions may resolve spontaneously or persist for weeks to months.

Diagnosis

A healthcare professional diagnoses reactive perforating collagenosis through a physical examination and clinical history. A skin biopsy may be performed to confirm the presence of extruded collagen and rule out other conditions. Histopathological examination typically shows transepidermal elimination of collagen fibers.

Treatment Options

• Topical Therapies: Corticosteroids or retinoids may reduce inflammation and promote lesion resolution.
• Systemic Medications: Oral retinoids or antibiotics may be used in severe or refractory cases.
• Lesion Management: Gentle debridement or cryotherapy can help remove keratotic plugs.
• Symptom Control: Antihistamines or moisturizers may alleviate pruritus.

Prognosis and Follow-Up

Reactive perforating collagenosis is generally a chronic condition with periods of remission and flare-ups. Lesions may resolve spontaneously but often recur. Long-term follow-up is recommended to monitor for complications and adjust treatment as needed. Management focuses on symptom control and addressing underlying triggers.

Complications

• Secondary infection from scratching or lesion disruption.
• Persistent scarring or hyperpigmentation at lesion sites.
• Psychological impact due to visible skin changes.

Lifestyle & Prevention

• Avoid skin trauma or irritation to reduce lesion triggers.
• Use gentle skincare products to maintain skin barrier function.
• Manage underlying conditions (e.g., diabetes, renal disease) that may exacerbate the condition.
• Protect skin from excessive sun exposure, which can worsen lesions.

When to Seek Professional Help

Seek medical attention if lesions become painful, infected, or rapidly increase in number. Consult a healthcare provider if pruritus is severe or interferes with daily activities. Prompt evaluation is recommended for persistent or worsening symptoms.

Tips for Medical Coders

When coding for reactive perforating collagenosis (ICD10CM code L87.1), ensure documentation supports the clinical diagnosis, including lesion characteristics, location, and any associated symptoms. Note any underlying conditions or triggers that may influence coding specificity. Verify that the code aligns with the provider's documented findings and treatment plan.